Literature DB >> 10468085

Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy.

D Aronson1, L A Weinrauch, J A D'Elia, G H Tofler, A J Burger.   

Abstract

Diabetes mellitus is associated with a marked increase in the risk of coronary events but with an altered circadian distribution that demonstrates an absent morning peak and higher infarction rate during the evening hours. To elucidate the mechanism of this phenomenon, the circadian pattern of heart rate variability was evaluated in 22 type I diabetic patients with diabetic autonomic neuropathy in conjunction with circadian changes of fibrinolytic and hemostatic factors. The circadian pattern (6 A.M. to 10 P.M. vs 10 P.M. to 6 A.M.) of 3 indexes of parasympathetic tone was evaluated using 24-hour heart rate variability analysis. The high-frequency power (3.0 +/- 0.2 vs 3.3 +/- 0.2 ms2, p = 0.08) and the percentage of RR intervals with >50 ms variation (0.47 +/- 0.18 vs 0.69 +/- 0.33 ms, p = 0.52) demonstrated no significant circadian variation. The square root of mean squared differences of successive RR intervals showed a small but significant increase during nighttime (8.5 +/- 0.7 vs 9.7 +/- 1.1 ms, p = 0.02). Fibrinolytic activity was significantly lower at 8 A.M. than at 4 P.M. (166.4 +/- 12.5 to 200.2 +/- 9.3 mm2, p = 0.0003), but with a low amplitude. Plasminogen activator inhibitor 1 showed no circadian variation. Factor VII and fibrinogen demonstrated a significant reduction from 8 A.M. to 4 P.M., but both peak and nadir values were elevated. The von Willebrand factor was markedly elevated with no circadian variation. Thus, diabetic autonomic neuropathy is associated with a loss of both the nocturnal predominance of parasympathetic activity and a prothrombotic state that persists throughout the day. These abnormalities may attenuate the relative protection from coronary events during the afternoon and nighttime.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468085     DOI: 10.1016/s0002-9149(99)00331-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Cardiovascular autonomic neuropathy: diagnosis and management.

Authors:  Aaron I Vinik; Tomris Erbas
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  Acute changes in heart rate variability in subjects with diabetes following a highway traffic exposure.

Authors:  Robert J Laumbach; David Q Rich; Sampada Gandhi; Louis Amorosa; Stephen Schneider; Junfeng Zhang; Pamela Ohman-Strickland; Jicheng Gong; Oleksiy Lelyanov; Howard M Kipen
Journal:  J Occup Environ Med       Date:  2010-03       Impact factor: 2.162

Review 3.  The Diabetic Cardiorenal Nexus.

Authors:  John A D'Elia; George P Bayliss; Larry A Weinrauch
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 4.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

5.  QT & RR variability spots the earliest autonomic deregulation in diabetes. Fading of vagal sino-atrial drive but not of sympathetic ventricular responsiveness to life challenges.

Authors:  Radu Negoes; Oana Istrătescu; Mihaela Dincă-Panaitescu; Erban Dincă-Panaitescu; Alin Achim
Journal:  Integr Physiol Behav Sci       Date:  2002 Apr-Jun

6.  Circadian variation on the onset of acute ST segment elevation myocardial infarction in diabetic subjects.

Authors:  Jing Li; Qi Hua; Lin Pi; Jing Tan; Boyu Li
Journal:  J Cardiovasc Dis Res       Date:  2010-01

Review 7.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

8.  Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes.

Authors:  Lydia Lacerda; Lionel H Opie; Sandrine Lecour
Journal:  Exp Diabetes Res       Date:  2012-10-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.